510(k) Report

510(k) · Cleared

Cleared

Perimed Transcutaneous PO2 and PCO2 Monitor (PF5040)

K990960510(k) TraditionalCleared Sep 23, 1999185-day reviewClass II21 CFR 868.2480

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Perimed, Inc. · LKD Monitor, Carbon-Dioxide, Cutaneous

Cleared on Sep 23, 1999 after a 185-day review. The FDA summary names its predicate without a number.

Decided
Sep 23, 1999
Review
185 days
Class
Class II
Product code
LKD
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K990960Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LKD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LKD device

  1. #1 K232516 Sentec Digital Monitoring System (SDMS) tCOM+score 10.1 · 10 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Novametrix TCOM Transcutaneous O₂/CO₂ Monitor
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LKD devices

LKD Monitor, Carbon-Dioxide, Cutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LKD

1in 2024

2010: 22011: 12013: 12015: 12024: 1
2007high 2 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LKD

Too few LKD 510(k)s in any year since 2007 to give a median.

Recalls per year · LKD

1in 2022

2009: 42011: 12012: 22014: 12016: 12022: 1
2007high 4 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LKD

3in 2025

2010: 82012: 42013: 12014: 212015: 202016: 42019: 32020: 62021: 22023: 12024: 12025: 3
2007high 21 (2014) · low 0 (2007)2025

MAUDE reports naming product code LKD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—40
20102—08
20111—10
20120—24
20131—01
20140—121
20151—020
20160—14
20170—00
20180—00
20190—03
20200—06
20210—02
20220—10
20230—01
20241—01
20250—03
20260—0—

What is it indicated for?

When installed in the Periflux System 5000, the Transcutaneous pO₂/pCO₂ Monitor (PF5040) is intended to monitor the levels of oxygen and/or carbon dioxide from tissue transcutaneously. The pO₂ monitor is intended only for use with infants not under gas anesthesia. The unit provides continuous, non-invasive monitoring of cutaneous oxygen and carbon dioxide. The Periflux System 5000 with the pO₂/pCO₂ module is intended to be used in hospitals and…

Read the full statement (109 words)

When installed in the Periflux System 5000, the Transcutaneous pO₂/pCO₂ Monitor (PF5040) is intended to monitor the levels of oxygen and/or carbon dioxide from tissue transcutaneously. The pO₂ monitor is intended only for use with infants not under gas anesthesia. The unit provides continuous, non-invasive monitoring of cutaneous oxygen and carbon dioxide.

The Periflux System 5000 with the pO₂/pCO₂ module is intended to be used in hospitals and physician's offices. It is intended to monitor transcutaneous pCO₂ in adults and infants with and without gas anesthesia and pO₂ in infants not under gas anesthesia. The system is not intended for use by patients without the supervision of a physician.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K990960: Perimed Transcutaneous PO2 and PCO2 Monitor (PF5040).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K990960

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026